-
effectivehealthcare.ahrq.gov/sites/default/files/zikmund.pdf
December 26, 2012 - Zikmund
Slide
1: The
Right Tool is What They
Need, Not What We
Have: A Taxonomy
of Appropriate
Levels of Precision in Patient Risk Communication
Brian J. Zikmund-‐Fisher, Ph.D.
Assistant Professor, Health Behavior & Health Education
University of Michigan School of…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/test-performance-metrics_appendixes.pdf
January 01, 2005 - A-1
Appendix: Test Performance Metrics
The basic definitions of test performance are based upon a 2×2 cross tabulation of the “true
disease status” and the test results (Appendix Table). Ostensibly simple, the information in a 2×2
table can be summarized in several ways—some of which are mathematically equivale…
-
effectivehealthcare.ahrq.gov/products/cardiology-health-outcomes/research
July 28, 2010 - In addition to calculating rates of carotid revascularization, we calculated rates of carotid imaging … Second, the absence of detailed clinical data prevented us from calculating risk-adjusted mortality rates
-
effectivehealthcare.ahrq.gov/products/chronic-kidney-disease-anemia-2011/research
October 12, 2012 - , 15 used classical markers of iron status to define “iron deficiency” as the reference standard in calculating
-
effectivehealthcare.ahrq.gov/products/quantitative-synthesis-expanded-methods/methods
March 13, 2013 - small (RR 1.07 95% CI 1.01–1.16). 27
To facilitate interpretation when RR or OR is used, we recommend calculating … To facilitate interpretation, the investigators could consider calculating an approximation of mean difference … For binary outcomes, consider calculating number need to treat (NNT) or number needed to harm (NNH) and
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization-cost_research.pdf
January 01, 2011 - Utilization and cost of anticancer biologic products
among Medicare beneficiaries, 2006-2009
Data Points #6Anticancer Biologics
From 2006 to 2009, over 800,000
Medicare fee-for-service
beneficiaries continuously
enrolled in Parts A and B had a
claim for an anticancer biologic
of interest.
Bevacizumab was the m…
-
effectivehealthcare.ahrq.gov/products/continuous-outcomes-correlation/research
November 19, 2012 - Empirical Assessment of Within-Arm Correlation Imputation in Trials of Continuous Outcomes
Research Report November 19, 2012 Web Version [NLM Site] Download Main Document PDF 4.4 MB
People using assistive technology may not be able to fully access information in these files. For additional assistance, p…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/quantitative-synthesis-expanded-methods_methods.pdf
March 01, 2013 - small (RR 1.07 95% CI 1.01–1.16).27
To facilitate interpretation when RR or OR is used, we recommend calculating … To facilitate interpretation, the investigators
could consider calculating an approximation of mean … • For binary outcomes, consider calculating number need to treat (NNT) or number
needed to harm (
-
effectivehealthcare.ahrq.gov/products/bayesian-mixed-treatment/research
January 31, 2013 - Findings of Bayesian Mixed Treatment Comparison Meta-Analyses: Comparison and Exploration Using Real-World Trial Data and Simulation
Research Report January 31, 2013 Web Version [NLM Site] Download Main Document PDF 2.4 MB
People using assistive technology may not be able to fully access information in …
-
effectivehealthcare.ahrq.gov/products/migraine-prevention/research
June 11, 2013 - Current Page Topic Timeline Jun. 2, 2011 Topic Initiated Nov. 3, 2011 Research Protocol Jun. 3, 2013 Topic Overview Jun. 11, 2013 Systematic Review Aug. 8, 2013 Disposition of Comments Report Migraine in Children: Preventive Pharmacologic Treatments
Systematic Review Archived June 11, 2013 Web Version [NLM Site] D…
-
effectivehealthcare.ahrq.gov/webform/products/pcor-depression/submit-comments
April 01, 2021 - Home »
Webform »
Products »
Pcor Depression »
Submit Comments
Open for comment:
Outcome Measure Harmonization and Data Infrastructure for Patient-Centered Outcomes Research in Depression
Research Report Draft April 1, 2021 Download Main Document PDF 1.8 MB
…
-
effectivehealthcare.ahrq.gov/sites/default/files/data-extraction.ppt
January 01, 2009 - Back-calculating the denominator (total number of people) from each proportion is even more amusing.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-quantitative-synthesis-chapter-1.pdf
July 01, 2019 - ► Rare outcomes: If included trials are underpowered for a valid result,
do not pool.7
− Consider calculating
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy_surveillance.pdf
July 01, 2012 - CER # 19:
Comparative Effectiveness of Core Needle Biopsy and Open
Surgical Biopsy for Diagnosis of Breast Lesions
Original release date: December, 2009
Surveillance Report 1st Assessment: December, 2011
Surveillance Report 2nd Assessment: July, 2012
Key Findings, 1st Assessment:
• For Key Question …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pharma-nonpharma-ptsd-2022-update-executive-summ.pdf
January 01, 2022 - Executive Summary_Systematic Review_Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: 2022 Update of the PTSD-Repository Evidence Base
Systematic Review
Pharmacologic and Nonpharmacologic Treatments
for Posttraumatic Stress Disorder: 2022 Update of
the PTSD-Repository Evidenc…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/trauma-child-interventions_disposition-comments.pdf
February 11, 2013 - Methods for
calculating confidence intervals when
sufficient information was given in the study
are
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-metaanalysis_methods.pdf
July 01, 2012 - correspond to
impossible summary sensitivities or specificities (outside the zero to one interval).23 Back-
calculating
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy-executive.pdf
December 01, 2009 - Layout 1
Background
Breast cancer is the second most common
malignancy of women, with over 180,000
new cases diagnosed each year in the
United States. Survival rates depend on the
stage of disease at diagnosis. Women
diagnosed with early stages of breast
cancer have a 5-year survival rate near 100
percent. However, …
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cardiology-health-outcomes_research.pdf
July 01, 2010 - In addition to calculating rates of carotid revascularization, we calculated rates of carotid
imaging … Second, the absence of detailed clinical data
prevented us from calculating risk-adjusted mortality
-
effectivehealthcare.ahrq.gov/sites/default/files/johnson_-ahrq-mcda-presentation.pdf
August 27, 2012 - Slide 1
Research Triangle Institute
RTI International is a trade name of Research Triangle Institute. www.rti.org
The Use of Conjoint Analysis to Elicit
Patient Preferences in Selecting
Treatment Endpoints
F. Reed Johnson, PhD
Distinguished Fellow and Principal Economist
Research Triangle Institute
I…